【摘要】 为了解我国犬细小病毒病的流行病学、防疫、诊断、治疗现状及存在问题,为该病的诊断、治疗及新药开发奠定基础,笔者于2008年12月分别对北京、西安、郑州、天津、汉中5个城市共30家动物医院开展问卷调查,统计结果表明,2006～2008年细小病毒病犬占治疗病犬总数的比例分别为15.64%、19.37%和20.51%,呈逐年上升趋势;病犬中接种过细小病毒疫苗的犬约占32.00%,且未接种的多为幼犬;在受调查的动物医院中,93.33%的医院使用进口疫苗,33.33%的医院使用国产疫苗;使用犬细小病毒检测试纸检测的医院占96.67%,其中所使用全部是韩国进口试纸;治愈时间平均为5.5d,治疗中多配合使用犬细小病毒单克隆抗体,使用率达90.00%,其费用占总治疗费用的42.70%,单抗产品已成为犬细小病毒病诊治的主要来源。我国还缺乏犬细小病毒病的临床数据,对该病的诊治还有很多方面需要进行深入研究,国产诊治药物亟待开发。更多还原

【Abstract】 The aim of the survey was to investigate epidemiology, diagnosis and therapy situation of canine parvovirus (CPV) disease, to find the problem of diagnosis and therapy in China, and to provide further data support for anti-CPV drug development.Questionnaire surveys were carried out in 30 veterinary clinics in Beijing, Xi’an, Zhengzhou, Tianjin and Hanzhong in December, 2008.The results showed that the proportion of CPV dogs in all clinic treated dogs were 15.64%, 19.37% and 20.51% in 2006, 2007 and 2008, respectively, with an increasing tendency.32.00% sick dogs were vaccinated.Most of the unvaccinated dogs were puppies.Imported vaccines were used in 93.33% clinics and homegrown vaccines were used in 33.33% clinics.96.67% clinics used CPV antigen test kit made in Korea.The average duration of treatment was 5.5d.90.00% clinics used CPV McAb, 42.70% of the total payment was expended in CPV McAb.However, CPV McAbs were usually combined used with other drugs in treatment.McAb productions were the main sources for CPV diagnosis and treatment.Information of CPV treatment was inadequate in China.More survey should be carry out and more technology should be developed in CPV diagnosis and therapy, especially the homegrown medicines.更多还原